BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29708168)

  • 1. International trends in the clinical epidemiology of malignant pleural mesothelioma.
    Damhuis RAM; van Meerbeeck JP
    J Thorac Dis; 2018 Mar; 10(3):1147-1148. PubMed ID: 29708168
    [No Abstract]   [Full Text] [Related]  

  • 2. Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis.
    Mezei G; Chang ET; Mowat FS; Moolgavkar SH
    Scand J Work Environ Health; 2021 Jan; 47(1):85-86. PubMed ID: 32626907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant Pleural Mesothelioma Epidemiology in the United States From 2000 to 2016.
    Thomas A; Karakattu S; Cagle J; Hoskere G
    Cureus; 2021 Apr; 13(4):e14605. PubMed ID: 34040906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.
    Bibby AC; Tsim S; Kanellakis N; Ball H; Talbot DC; Blyth KG; Maskell NA; Psallidas I
    Eur Respir Rev; 2016 Dec; 25(142):472-486. PubMed ID: 27903668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines.
    Strickler HD; Goedert JJ; Devesa SS; Lahey J; Fraumeni JF; Rosenberg PS
    J Natl Cancer Inst; 2003 Jan; 95(1):38-45. PubMed ID: 12509399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CREST biorepository: a tool for molecular epidemiology and translational studies on malignant mesothelioma, lung cancer, and other respiratory tract diseases.
    Ugolini D; Neri M; Canessa PA; Casilli C; Catrambone G; Ivaldi GP; Lando C; Marroni P; Paganuzzi M; Parodi B; Visconti P; Puntoni R; Bonassi S
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3013-9. PubMed ID: 18990743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, diagnosis and treatment of the malignant pleural mesothelioma, a narrative review of literature.
    Schumann SO; Kocher G; Minervini F
    J Thorac Dis; 2021 Apr; 13(4):2510-2523. PubMed ID: 34012597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of malignant pleural mesothelioma - part 1: epidemiology, diagnosis, and staging : Consensus of the Austrian Mesothelioma Interest Group (AMIG).
    Geltner C; Errhalt P; Baumgartner B; Ambrosch G; Machan B; Eckmayr J; Klikovits T; Hoda MA; Popper H; Klepetko W;
    Wien Klin Wochenschr; 2016 Sep; 128(17-18):611-7. PubMed ID: 27619223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Adult Pleural Disease in the United States.
    Mummadi SR; Stoller JK; Lopez R; Kailasam K; Gillespie CT; Hahn PY
    Chest; 2021 Oct; 160(4):1534-1551. PubMed ID: 34023322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the biology of malignant pleural mesothelioma.
    Zucali PA; Ceresoli GL; De Vincenzo F; Simonelli M; Lorenzi E; Gianoncelli L; Santoro A
    Cancer Treat Rev; 2011 Nov; 37(7):543-58. PubMed ID: 21288646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considerations for Imaging of Malignant Pleural Mesothelioma: A Consensus Statement from the International Mesothelioma Interest Group.
    Katz SI; Straus CM; Roshkovan L; Blyth KG; Frauenfelder T; Gill RR; Lalezari F; Erasmus J; Nowak AK; Gerbaudo VH; Francis RJ; Armato SG
    J Thorac Oncol; 2023 Mar; 18(3):278-298. PubMed ID: 36549385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse malignant pleural mesothelioma in an urban hospital: clinical spectrum and trend in incidence over time.
    Shepherd KE; Oliver LC; Kazemi H
    Am J Ind Med; 1989; 16(4):373-83. PubMed ID: 2610210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
    Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
    Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of new imaging techniques in diagnosis and staging of malignant pleural mesothelioma.
    Eibel R; Tuengerthal S; Schoenberg SO
    Curr Opin Oncol; 2003 Mar; 15(2):131-8. PubMed ID: 12601277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent mortality from pleural mesothelioma, historical patterns of asbestos use, and adoption of bans: a global assessment.
    Nishikawa K; Takahashi K; Karjalainen A; Wen CP; Furuya S; Hoshuyama T; Todoroki M; Kiyomoto Y; Wilson D; Higashi T; Ohtaki M; Pan G; Wagner G
    Environ Health Perspect; 2008 Dec; 116(12):1675-80. PubMed ID: 19079719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant pleural mesothelioma with an unusual radiologic manifestation].
    Jover-Sáenz A; Vilà-Justribó M; Salud-Salvià A; Porcel-Pérez JM; Vicente de Vera P
    An Med Interna; 1999 Jul; 16(7):354-6. PubMed ID: 10481335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982-2009.
    Soeberg MJ; Leigh J; Driscoll T; Armstrong B; Young JM; van Zandwijk N
    Occup Environ Med; 2016 Mar; 73(3):187-94. PubMed ID: 26800709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and Clinical Aspects of Malignant Pleural Mesothelioma.
    Brims F
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study.
    Yildirim H; Metintas M; Entok E; Ak G; Ak I; Dundar E; Erginel S
    J Thorac Oncol; 2009 Dec; 4(12):1480-4. PubMed ID: 19875971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of the expression of tumor-associated antigen, RCAS1, and its soluble protein in pleural fluid in malignant mesothelioma.
    Hiraki A; Aoe K; Murakami T; Nakamura Y; Yamazaki K; Sueoka N; Taguchi K; Kamei T; Maeda T; Takeyama H; Kishimoto T; Nishimura M; Sugi K
    Oncol Rep; 2005 Aug; 14(2):357-62. PubMed ID: 16012715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.